Skip to content
Home/Companies/Biotech/Extend
Extend

Extend

Biotech·Italy·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Extend?

Extend is currently owned by Angelini Ventures through Angelini Ventures (2022 vintage), since 2022.

Hand-verified · updated 2026-07-26

Angelini Ventures
Investor
Angelini Ventures
Angelini Ventures · 2022 · Life Sciences VC

Key facts

HQItaly
SectorBiotech
StatusActive
Websiteextend-tthub.com

More from Angelini Ventures

Other portfolio companies in the same fund.

Epicrispr Biotechnologies
Active
United States· 2026
Handspring Health
Active
HealthTechUS· 2026
Hypervision Surgical
Active
MedTechUK· 2026
MMI (Medical Microinstruments)
Active
United States / Italy· 2026
Adcytherix
Active
BiotechFrance· 2025
Elkedonia
Elkedonia
Active
BiotechFrance· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue